Kevin Patrick Danahy insider trades
Open-market stock purchases and sales by Kevin Patrick Danahy, Chief Commercial Officer at Pulse Biosciences, Inc, from SEC Form 4 filings since Feb 14, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 18, 2026 | PLSE Pulse Biosciences, Inc | Sold | $118K |
| Feb 18, 2026 | PLSE Pulse Biosciences, Inc | Bought (not open market) | — |
| Feb 17, 2026 | PLSE Pulse Biosciences, Inc | Sold | $473K |
| Feb 17, 2026 | PLSE Pulse Biosciences, Inc | Bought (not open market) | — |
| Feb 13, 2026 | PLSE Pulse Biosciences, Inc | Bought (not open market) | — |
| Feb 13, 2026 | PLSE Pulse Biosciences, Inc | Sold | $471K |
| Feb 12, 2026 | PLSE Pulse Biosciences, Inc | Sold | $467K |
| Feb 12, 2026 | PLSE Pulse Biosciences, Inc | Bought (not open market) | — |
| Feb 11, 2026 | PLSE Pulse Biosciences, Inc | Bought (not open market) | — |
| Feb 11, 2026 | PLSE Pulse Biosciences, Inc | Sold | $504K |
| Feb 10, 2026 | PLSE Pulse Biosciences, Inc | Sold | $470K |
| Feb 10, 2026 | PLSE Pulse Biosciences, Inc | Bought (not open market) | — |
| Feb 9, 2026 | PLSE Pulse Biosciences, Inc | Sold | $429K |
| Feb 9, 2026 | PLSE Pulse Biosciences, Inc | Bought (not open market) | — |
Companies traded
- PLSE Pulse Biosciences, Inc: 5 buys, 10 sales, last Feb 18, 2026
Get free alerts when Kevin Patrick Danahy files a new trade →